Method of treating disease states by the administration of 1.alpha.,25,26-trihydroxycholecalciferol
US4617297A · kind A · utility
12Cited by
3References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 1984 |
| Grant date | Oct 14, 1986 |
| Priority date | — |
| Expiry date | Apr 3, 2004 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/59
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the method of treating disease states characterized by higher than normal levels of endogenously produced 1.alpha.,25 dihydroxy-cholecalciferol or conditions where there is an increased sensitivity to 1.alpha., 25 dihydroxy-cholecalciferol by administering to an organism suffering from such a disease state a pharmaceutically effective amount of the R or S epimer of 1.alpha.,25,26 trihydroxy-cholecalciferol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.